American Vanguard reported Q3 2023 financial results, showing net sales of $149.5 million, which is in line with the prior year. However, the company experienced a net loss of $325 thousand, a significant decrease compared to the net income of $6.7 million in Q3 2022. The company is implementing a transformation plan to improve future growth, operational efficiency, and profitability.
Q3 sales were in line with the prior year despite global destocking by customers.
Strong sales were recorded for the premier corn soil insecticide Aztec and soil fumigants in the Pacific Northwest.
US non-crop business is seeing more normalized trends in nursery, ornamental, and professional products.
International businesses are still feeling the effects of low-priced generic products in certain regions, especially Central America, while Mexico and Australia remain strong.
The company anticipates improved sales and profitability in the fourth quarter as compared to the first nine months of this fiscal year. They are targeting full year 2023 net sales of $580 million - $590 million, a gross margin of 30%-32%, and an adjusted EBITDA of $55 million - $59 million.
Visualization of income flow from segment revenue to net income